论文信息 - Do Sulfonylureas Influence Hepatic Insulin Clearance?

Do Sulfonylureas Influence Hepatic Insulin Clearance?

ship of metabolic clearance rate of insulin to body mass index. Metabolism 36:219-22, 1987 Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 33:486-94, 1984 Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA: Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am ) Physio! 244:E517-27, 1983 Castillo M, Scheen AJ, Paolisso G, Lefebvre PJ: The addition of glipizide to insulin therapy in type 2 diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. Ada Endocrinol 116:364-72, 1987

[1] B. W. Tucker,et al. Hypoglycemic actions of tolbutamide and carbutamide. , 1956, Metabolism: clinical and experimental.

[2] A. Scheen,et al. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients , 2004, European Journal of Clinical Pharmacology.

[3] I. Mirsky,et al. The inhibition of insulinase by hypoglycemic sulfonamides. , 1956, Metabolism: clinical and experimental.

[4] L. Groop,et al. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. , 1987, Diabetes care.

[5] H. Kuzuya. [C peptide and pro-insulin]. , 1977, Nihon rinsho. Japanese journal of clinical medicine.

[6] R. Hamman,et al. The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus , 1985, Diabetes.

[7] L. Groop,et al. Therapeutic equivalence of once- and thrice-daily glipizide , 2004, European Journal of Clinical Pharmacology.

[8] K. Polonsky,et al. C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations , 1984, Diabetes.